Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.

Samankaltaisia teoksia

• Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
  Tekijä: Rybak, M J, et al.
  Julkaistu: (1997)
• Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
  Tekijä: Houlihan, H H, et al.
  Julkaistu: (1997)
• Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots.
  Tekijä: Kang, S L, et al.
  Julkaistu: (1995)
• Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
  Tekijä: McGrath, B J, et al.
  Julkaistu: (1994)
• Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots.
  Tekijä: Turcotte, A, et al.
  Julkaistu: (1992)